Vermont § 2071 - Definitions As used in this subchapter: (1) “Individual with disabilities” means an individual who is under age 65 and is entitled, under the Social Security Act, to disability insurance benefits or is eligible for

§ 2071. Definitions As used in this subchapter: (1) “Individual with disabilities” means an individual who is under age 65 and is entitled, under the Social Security Act, to disability insurance benefits or is eligible for

• Medicare. (2) “Maintenance drug” means a drug approved by the federal Food and Drug Administration
  for continuous use and prescribed to treat a chronic condition for a prolonged period
  of time of 30 days or longer and includes insulin, an insulin syringe, and an insulin
  needle. (3) “Medicare Part D” means the prescription drug program established under the Medicare
  Prescription Drug, Improvement and Modernization Act of 2003, Pub. L. No. 108-173,
  including the prescription drug plans offered pursuant to the act. (4) “DVHA” means the Department of Vermont Health Access. (5) “Pharmaceutical” means a drug that may not be dispensed unless prescribed by a health
  care provider as defined by 18 V.S.A. § 9402(7) acting within the scope of the provider’s license. The term excludes a drug determined
  less than effective under the federal Food, Drug and Cosmetics Act. (6) “Pharmacy” means a retail or institutional drug outlet licensed by the Vermont State
  Board of Pharmacy pursuant to 26 V.S.A. chapter 36, or by an equivalent board in another
  state, in which pharmaceuticals are sold at retail and that has entered into a written
  agreement with the State to dispense pharmaceuticals in accordance with the provisions
  of this chapter. (Added 2005, No. 71, § 314; amended 2009, No. 156 (Adj. Sess.), § I.70; 2013, No. 131 (Adj. Sess.), § 48, eff. May 20, 2014.)